Caris Life Sciences Inc (CAI) reports a 125% revenue increase, positive net income, and ambitious 2026 growth targets, driven by molecular profiling success and upcoming innovations.

Political upheaval is brewing across the pond as the United Kingdom grapples with severe discontent over Prime Minister Keir Starmer's leadership. Recent parliamentary failures have ignited a deep ...

Full year revenue growth of 97% driven by strong performance in molecular profiling services Expects full year 2026 revenue to be in the range of $1.0 billion to $1.02 ...